Allspring Global Investments
ASND icon

Allspring Global Investments’s Ascendis Pharma A/S ASND Stock Holding History

Allspring Global Investments’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.9M Sell
178,738
-5,486
-3% -$1.28M 0.07% 310
2026
Q1 		$42M Sell
184,224
-3,418
-2% -$766K 0.07% 326
2025
Q4 		$40M Sell
187,642
-4,030
-2% -$832K 0.06% 350
2025
Q3 		$39.1M Sell
191,672
-8,585
-4% -$1.6M 0.06% 359
2025
Q2 		$34.4M Buy
200,257
+10,644
+6% +$1.73M 0.06% 380
2025
Q1 		$28.7M Buy
189,613
+36,875
+24% +$5.27M 0.05% 429
2024
Q4 		$21.1M Sell
152,738
-8,672
-5% -$1.14M 0.03% 520
2024
Q3 		$24.1M Sell
161,410
-17,842
-10% -$2.41M 0.04% 510
2024
Q2 		$24.4M Sell
179,252
-9,956
-5% -$1.35M 0.04% 499
2024
Q1 		$28.6M Sell
189,208
-13,964
-7% -$1.99M 0.04% 475
2023
Q4 		$25.6M Sell
203,172
-9,823
-5% -$979K 0.04% 491
2023
Q3 		$19.9M Sell
212,995
-11,524
-5% -$1.08M 0.04% 556
2023
Q2 		$20M Sell
224,519
-15,696
-7% -$1.37M 0.03% 597
2023
Q1 		$25.8M Sell
240,215
-10,355
-4% -$1.18M 0.04% 512
2022
Q4 		$30.6M Sell
250,570
-5,358
-2% -$622K 0.05% 455
2022
Q3 		$26.4M Sell
255,928
-7,781
-3% -$738K 0.05% 487
2022
Q2 		$24.5M Sell
263,709
-4,886
-2% -$460K 0.04% 519
2022
Q1 		$31.5M Sell
268,595
-7,358
-3% -$852K 0.04% 517
2021
Q4 		$37.1M Buy
+275,953
New +$41M 0.04% 526

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Allspring Global Investments's ASND Position: Q2 2026 in Review

Allspring Global Investments reduced its Ascendis Pharma A/S (ASND) stake by 3% in Q2 2026, selling an estimated $1.28M and leaving 178,738 shares worth $47.9M. The position accounts for 0.07% of the portfolio, ranked #310.

Allspring Global Investments first reported a position in ASND in Q4 2021 and has held it in 19 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Allspring Global Investments held 178,738 shares of Ascendis Pharma A/S worth $47.9M as of Q2 2026.
  • Allspring Global Investments sold 5,486 Ascendis Pharma A/S shares in Q2 2026, an estimated $1.28M.
  • Ascendis Pharma A/S made up 0.07% of Allspring Global Investments's portfolio in Q2 2026, its #310 holding.
  • Allspring Global Investments first reported a position in Ascendis Pharma A/S in Q4 2021 and has held it in 19 quarters since.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.